Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Korea Institute of Science and Technology identifies TNK2/MAP4K2 inhibitors

Aug. 10, 2021

First patient dosed in phase Ib/II study of AVB-500 in pancreatic adenocarcinoma

Aug. 10, 2021

Antengene and MindRank AI collaborate to advance difficult-to-drug molecular targets

Aug. 9, 2021

New SHP-2 inhibitors identified at Beijing Innocare Pharmaceutical Technology

Aug. 9, 2021

Jiangsu Hengrui Medicine, Shanghai Hengrui Pharmaceutical patent PROTACs targeting cereblon

Aug. 9, 2021

FDA places partial clinical hold on Aprea's myeloid malignancy programs

Aug. 6, 2021

First patient dosed in IMP-MEL study of PORT-2 for the treatment of melanoma and NSCLC

Aug. 6, 2021

Hisun Accuray Therapeutics, Zhejiang Hisun Pharmaceutical present SHP-2 inhibitors

Aug. 6, 2021

Jiangsu Hengrui Medicine, Shanghai Hengrui Pharmaceutical patent cereblon ligands

Aug. 6, 2021

Suzhou Zelgen Biosciences discovers G12C mutant GTPase KRAS inhibitors

Aug. 6, 2021

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...